Astellas Pharma Inc. - Interest Expense

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Interest-Expense" stands at 16.72 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.

Astellas Pharma Inc.'s second quarter result of 2.69 Billion JPY for the item "Interest Expense" represents a decrease of -54.34 percent compared to it's first quarter result.

Also, Astellas Pharma Inc.'s second quarter result of 2.69 Billion JPY for the item "Interest Expense" represents a decrease of -46.65 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Astellas Pharma Inc.'s second quarter result of 16.72 Billion JPY for the item "Interest Expense" represents a decrease of -12.34 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.00 percent compared to the value the year prior.
The 1 year change in percent is 1.00.
The 3 year change in percent is 184.39.
The 5 year change in percent is 632.91.
The 10 year change in percent is 1,842.51.

The Serie's long term average value is 4.59 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 264.50 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is +119,364.29%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is -12.34%.